Vasorelaxant effect of olprinone, an inhibitor of phosphodiesterase 3, on mesenteric small artery and vein of rabbits

被引:12
|
作者
Fujimoto, S [1 ]
Ohashi, M [1 ]
Hiramoto, A [1 ]
Inoue, Y [1 ]
Nagai, K [1 ]
Shiokawa, H [1 ]
Itoh, T [1 ]
机构
[1] Nagoya City Univ, Sch Med, Dept Pharmacol, Mizuho Ku, Nagoya, Aichi 4678601, Japan
关键词
mesenteric small artery; mesenteric vein; norepinephrine; olprinone; phosphodiesterase; 3;
D O I
10.1016/S0014-2999(98)00406-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effects of olprinone, a cardiotonic agent that inhibits cyclic GMP (cGMP)-inhibited phosphodiesterase, was studied on isolated rabbit mesenteric small artery and vein. In the presence of indomethacin and propranolol, olprinone at concentrations of 10 nM to 10 mu M and 1 mu M to 100 mu M relaxed norepinephrine-stimulated mesenteric artery and vein in a concentration-dependent manner, respectively. The relaxation was not endothelium-dependent in the artery. Removal of the endothelium however, increased marginally the response of the vein to olprinone. Olprinone-induced relaxation was less pronounced in arteries contracted with high KCl solution + norepinephrine than in those contracted with norepinephrine alone. Nicardipine inhibited this attenuating effect of high KCI solution on the olprinone-induced relaxation. Olprinone (1 mu M) enhanced the relaxation of artery and vein in response to a cAMP-increasing agent, 6-(3-dimethylaminopropionyl) forskolin (NKH477), but not to a cGMP- increasing agent, glyceryl trinitrate. Norepinephrine(10 mu M) and caffeine (5 mM) elicited a transient, phasic contraction of the artery in Ca2+-free solution. Both olprinone and NKH477 attenuated more potently the norepinephrine-induced contraction than the caffeine-induced contraction. When norepinephrine (10 mu M) and caffeine (5 mM) were successively applied in Ca2+-free solution, the contractile effect of caffeine was diminished compared to that in artery which had not been pretreated with norepinephrine. When the contraction in response to norepinephrine was partially attenuated by 1 mu M olprinone, the following contraction evoked by caffeine was enlarged. It is concluded that olprinone relaxes the small artery more strongly than the vein via its direct action on smooth muscles. It is suggested that olprinone attenuates norepinephrine-induced contraction through inhibition of receptor-operated transmembrane Ca2+ influx and Ca2+ release from intracellular storage sites. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:239 / 246
页数:8
相关论文
共 50 条
  • [1] Vasorelaxant effect of a phosphodiesterase 3 inhibitor, olprinone, on isolated human radial artery
    Adachi, H
    Kamata, S
    Kodama, K
    Nagakura, T
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 396 (01) : 43 - 47
  • [2] Bronchodilator effect of inhaled olprinone, a phosphodiesterase 3 inhibitor, in asthmatic patients
    Myou, S
    Fujimura, M
    Kamio, Y
    Ishiura, Y
    Tachibana, H
    Hirose, T
    Hashimoto, T
    Matsuda, T
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 160 (03) : 817 - 820
  • [3] Effects of a phosphodiesterase 3 inhibitor, olprinone, on rhythmical change in tension of human gastroepiploic artery
    Adachi, H
    Kakiki, M
    Kishi, Y
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2005, 528 (1-3) : 137 - 143
  • [4] Phosphodiesterase Inhibitor Effect on Small Artery Function in Preeclampsia
    Samangaya, Rebekah A.
    Wareing, Mark
    Skillern, Laurence
    Baker, Philip N.
    HYPERTENSION IN PREGNANCY, 2011, 30 (02) : 144 - 152
  • [5] INVITRO PULMONARY VASORELAXANT EFFECT OF THE PHOSPHODIESTERASE INHIBITOR ENOXIMONE
    BUTT, AY
    DINHXUAN, AT
    PEPKEZABA, J
    CREMONA, G
    CLELLAND, CA
    HIGENBOTTAM, TW
    ANGIOLOGY, 1993, 44 (04) : 289 - 294
  • [6] Effect of olprinone, a phosphodiesterase III inhibitor, on arterial wall distensibility: differentiation between aorta and common carotid artery
    Seki, M
    Mizushige, K
    Ueda, T
    Kitadai, M
    Matsuo, H
    HEART AND VESSELS, 1999, 14 (05) : 224 - 231
  • [7] Effect of olprinone, a phosphodiesterase III inhibitor, on arterial wall distensibility: Differentiation between aorta and common carotid artery
    Makoto Seki
    Katsufumi Mizushige
    Takashi Ueda
    Masaya Kitadai
    Hirohide Matsuo
    Heart and Vessels, 1999, 14 : 224 - 231
  • [8] Vasorelaxant effect of phosphodiesterase-inhibitor milrinone in the human radial artery used as coronary bypass graft
    He, GW
    Yang, CQ
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2000, 119 (05): : 1039 - 1045
  • [9] The neuroprotection of olprinone, a phosphodiesterase 3 inhibitor, on global cerebral ischemia in rats.
    Kakihana, Yasuyuki
    Yasuda, Tomotsugu
    Imabayashi, Toru
    Okayama, Naoko
    Kanmura, Yuichi
    Fujikawa, Kohsho
    Miyata, Atsuro
    CRITICAL CARE MEDICINE, 2006, 34 (12) : A37 - A37
  • [10] Possible mechanisms underlying the vasodilatation induced by olprinone, a phosphodiesterase III inhibitor, in rabbit coronary artery
    Ohashi, M
    Dohi, Y
    Itoh, T
    BRITISH JOURNAL OF PHARMACOLOGY, 2000, 129 (05) : 1000 - 1006